title: High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDL.
abstract: Withdrawing growth factors or serum from endothelial cells leads to the activation of effector caspases 3 and 7, resulting in apoptotic cell death. HDL protects against caspase induction through sphingosine-1-phosphate (S1P) receptors. This anti-caspase activity of HDL is antagonized by VLDL from apolipoprotein E4 (apoE4) (genotype, APOE4/4; apolipoprotein, apoE) targeted replacement (TR) mice, but not by VLDL from TR APOE3/3 mice, and requires the binding of apoE4-VLDL to an LDL receptor family member. In the absence of HDL, apoE4-VLDL and apoE3-VLDL from TR mice have limited antiapoptotic activity. In contrast, we show here that a high-fat/high-cholesterol/cholate diet (HFD) radically alters this biological activity of VLDL. On HFD, both apoE3-VLDL and apoE4-VLDL (HFD VLDL) inhibit caspase 3/7 activation initiated by serum withdrawal. This activity of HFD VLDL is independent of an LDL receptor family member but requires the activation of S1P(3) receptors, as shown by the ability of pharmacological block of S1P receptors by VPC 23019 and by small interfering RNA-mediated downregulation of S1P(3) receptors to inhibit HFD VLDL anticaspase activity.
authors.affiliation: Deane Laboratory, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: Mirta
authors.initials: M
authors.lastname: Mihovilovic
authors.forename: Jennifer B
authors.initials: JB
authors.lastname: Robinette
authors.forename: Robert M
authors.initials: RM
authors.lastname: DeKroon
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Sullivan
authors.forename: Warren J
authors.initials: WJ
authors.lastname: Strittmatter
mesh_terms: D000818:Animals; D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D017209:Apoptosis / Q000187:drug effects*; D061945:Caspase Inhibitors; D020169:Caspases / Q000378:metabolism; D002470:Cell Survival; D002784:Cholesterol / Q000494:pharmacology*; D004032:Diet; D004041:Dietary Fats / Q000494:pharmacology*; D008075:Lipoproteins, HDL / Q000502:physiology; D008079:Lipoproteins, VLDL / Q000502:physiology*; D051379:Mice; D008822:Mice, Transgenic; D049349:Receptors, Lysosphingolipid / Q000502:physiology*
chemical_list: D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D061945:Caspase Inhibitors; D004041:Dietary Fats; D008075:Lipoproteins, HDL; D008079:Lipoproteins, VLDL; D049349:Receptors, Lysosphingolipid; D002784:Cholesterol; D020169:Caspases